Amitis Capital Accelerates Digital Asset Capabilities With Samara Alpha Integration
Amitis Capital has integrated Samara Alpha, bringing its team, products and infrastructure into the group as it expands its institutional digital asset platform. NEW YORK and LONDON, April 30, 2026 /PRNewswire/ -- Amitis Capital, the asset...
Bybit EU Cooperates with PayPal to Simplify Crypto Funding
VIENNA, March 17, 2026 /PRNewswire/ -- Bybit EU, the European arm of Bybit and a MiCAR-licensed crypto-asset service provider headquartered in Vienna, today announced the integration of PayPal as a new fiat funding and withdrawal method across EEA...
Clapp Finance Launches Flexible Savings: Up to 5.2% APY With Instant Access
PRAGUE, Jan. 20, 2026 /PRNewswire/ -- Clapp Finance, an all-in-one crypto management platform, has introduced Flexible Savings. This high-yield product lets users earn competitive interest on crypto, stablecoins and euros without locking funds away,...
Bybit Releases Its 29th Proof-of-Reserves Report
DUBAI, UAE, Dec. 24, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, announced the publication of its 29th Proof-of-Reserves (PoR) snapshot, reflecting data accurate as of Dec. 17, 2025. The report,...
Bitget x AB Carnival: Share 235,502,000 $AB Worth $3.5 Million
SINGAPORE, March 4, 2025 /PRNewswire/ -- To celebrate the listing of $AB, Bitget (bitget.com) and AB DAO have launched the PoolX & CandyBomb dual airdrop event, rewarding BGB, BTC, ETH holders as well as deposit and trading participants. Tens of...
Fully Backed Within 72 hours: Bybit Maintains 1:1 Customer Assets Ratio in Latest Proof of Reserves Audited Report by Hacken
DUBAI, UAE, Feb. 24, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, has completed a fresh round of audit on Feb. 23, 2025 conducted by leading cybersecurity firm Hacken. The independent third-party...
2024 ESMO Asia: TransThera announces clinical data of tinengotinib in combination with atezolizumab (PD-L1) in biliary tract carcinoma (BTC)
NANJING, China and GAITHERSBURG, Md., Dec. 9, 2024 /PRNewswire/ -- TransThera Sciences Nanjing, Inc. (the "TransThera") announced the poster presentation at the 2024 European Society For Medical Oncology (ESMO) Asia Congress to discuss the clinical...